MarketFriction

Albert David Ltd

NSE ALBERTDAVD · BSE 524075 · Pharmaceuticals
₹856.70 -1.78%
NSE close2026-10-01
52 week range579.90 - 931.85
Market cap₹499 Cr.
P/E22.1
Price band 20% Delivery 82.3%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9388898998837571879086101
Expenses778079889282808185798391
Operating Profit16810161-5-11311311
OPM %17%9%11%1.0%6%0.8%-6%-15%2.9%12%3.2%10%
Other Income1217102321-9-522-212-2528
Interest000000011101
Depreciation122222222232
Profit before tax2723182225-10-128-320-2536
Tax %24%20%29%15%28%-8%-13%6%28%23%-15%11%
Net Profit2019131918-9-108-315-2132
EPS in Rs35.5732.8022.6233.0131.66-16.45-18.1013.91-5.7826.81-37.5556.07
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales318293285316320246313341362345333364
Expenses286266267286289227272297315342327338
Operating Profit3127183030194144473627
OPM %10%9%6%10%10%8%13%13%13%0.9%1.7%7%
Other Income43891571716155830713
Interest211111110133
Depreciation98878899771010
Profit before tax63261838292747519725128
Tax %24%39%45%29%34%19%25%29%22%32%379%
Net Profit48161027192235367517-123
EPS in Rs84.1027.9617.2446.6833.5938.7961.7863.38132.1530.14-2.6139.55
Dividend Payout %7%20%32%13%21%15%15%14%9%17%-192%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth0%6%-1%11%
Compounded Profit Growth%%%259%
Stock Price CAGR11%8%4%12%
Return on Equity9%10%8%0%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital666666666666
Reserves87131177180205217239274306377387386
Borrowings302030280226531230
Other Liabilities7167717684959511610611210798
Total Liabilities193224285290295320341401423498511519
Fixed Assets4944878377918488808399100
CWIP5595521137221
Investments16485968113122138183193273260243
Other Assets12212713013499106119130148135151155
Total Assets193224285290295320341401423498511519
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity28682030323037401146-28-8
Cash from Investing Activity-9-38-36-11-19-20-37-40-5-3323-4
Cash from Financing Activity-18-187-5-17-10-2-2-6-8012
Net Cash Flow112-1015-4-0-2-1-14-5-0
Free Cash Flow1862-03145153532635-43-36
CFO/OP95%303%115%204%126%149%202%129%59%131%-629%-47%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days474141352534292932302937
Inventory Days176187217173151148151124149126201187
Days Payable103102117127102132104969598118104
Cash Conversion Cycle12012614181745076578758112120
Working Capital Days272524102118-10-3414-1361
ROCE %18%17%15%7%18%14%12%17%17%28%6%1%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters62.04%62.04%62.13%62.13%62.13%62.13%62.23%62.23%62.23%62.23%62.23%62.23%
FIIs0.57%0.70%0.98%0.80%0.88%0.86%1.00%0.84%0.60%0.60%0.58%0.57%
DIIs1.90%1.67%1.67%1.67%1.63%1.63%1.64%1.65%1.65%1.65%1.65%1.63%
Public35.49%35.60%35.23%35.41%35.36%35.39%35.12%35.27%35.50%35.51%35.52%35.56%
No. of Shareholders9,90710,04111,26612,34913,59014,83015,30415,07014,66613,96713,55513,155

Fundamentals

Market Cap₹ 499 Cr.
Current Price₹ 876
Stock P/E22.1
Book Value₹ 686
ROCE0.82 %
ROE-0.44 %
Dividend Yield0.57 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)11%
Compounded Profit Growth (TTM)259%
Standalone figures.
Valuation
Market capRs 489 Cr
Enterprise valueRs 486 Cr
P/E (TTM)21.66x
Price to book1.25x
Price to sales1.34x
EV / EBITDA12.10x
EV / EBIT15.93x
EV / sales1.33x
Earnings yield4.62%
Dividend yield0.58%
P/E, 3-year average17.49x
P/B, 3-year average1.21x
P/E, 5-year average12.91x
P/B, 5-year average1.13x
Profitability
Operating margin (excl. other income)1.72%
Operating margin (incl. other income)3.96%
EBITDA margin11.02%
Pre-tax margin7.65%
Net profit margin6.19%
Net margin, latest quarter31.58%
ROE-0.38%
ROCE0.83%
ROA-0.29%
ROE, 3-year average8.59%
ROCE, 3-year average11.71%
ROA, 3-year average6.50%
ROE, 5-year average10.29%
ROCE, 5-year average14.05%
ROA, 5-year average7.55%
ROIC (approx.)-21.92%
Tax rate379.25%
Other income / net worth1.90%
Growth
Sales growth (latest year)-3.54%
Profit growth (latest year)-108.66%
Sales CAGR, 3 years-0.83%
Sales CAGR, 5 years6.20%
Sales growth QoQ18.03%
Sales growth YoY (latest quarter)43.60%
Profit growth YoY (latest quarter)303.02%
Per share
EPS (TTM)Rs 39.55
EPS (latest year)Rs -2.61
EPS (latest quarter)Rs 56.07
EPS, 3-year averageRs 53.23
EPS, 5-year averageRs 56.97
Book value per shareRs 686.05
Sales per shareRs 638.44
Cash flow per shareRs -13.42
Free cash flow per shareRs -63.08
Dividend per share (latest year)Rs 5.01
Dividend per share, 3-year averageRs 7.18
Dividend per share, 5-year averageRs 7.91
Dividends
Dividend payout, 3-year average12.67%
Dividend payout, 5-year average13.53%
Efficiency
Asset turnover0.64x
Fixed asset turnover3.34x
Inventory turnover2.37x
Inventory days154 days
Debtor days37 days
Debtors turnover9.81x
Creditor days104 days
Cash conversion cycle120 days
Working capital days1 days
Leverage
Total debtRs 30 Cr
Cash and bankRs 33 Cr
Net debtRs -3 Cr
Debt to equity0.08x
Net debt / EBITDA-0.08x
Interest coverage11.73x
Owners' fund to total sources75.42%
Debt to assets5.70%
Cash flow
Cash from Operating Activity (latest year)Rs -8 Cr
Cash from Investing Activity (latest year)Rs -4 Cr
Cash from Financing Activity (latest year)Rs 12 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -36 Cr
FCFE (approx.: FCF + change in debt)Rs -19 Cr
Cash from ops / profit, 5 years0.38x
Statement figures
Net sales (TTM)Rs 364 Cr
Net sales (latest year)Rs 333 Cr
Sales (latest quarter)Rs 101 Cr
Operating profit excl. other income (latest year)Rs 6 Cr
Operating profit (latest quarter)Rs 11 Cr
Other income (TTM)Rs 13 Cr
EBITDA (TTM)Rs 40 Cr
PBDT (TTM)Rs 38 Cr
Profit before tax (TTM)Rs 28 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 23 Cr
Net profit (latest year)Rs -1 Cr
Net profit (latest quarter)Rs 32 Cr
Depreciation (TTM)Rs 10 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 138 Cr
Total expenditure (latest year)Rs 327 Cr
Total income (latest year)Rs 340 Cr
Share capitalRs 6 Cr
ReservesRs 386 Cr
Shareholders' fundsRs 392 Cr
Total assetsRs 519 Cr
Net blockRs 100 Cr
Capital work in progressRs 21 Cr
InvestmentsRs 243 Cr
ReceivablesRs 34 Cr
InventoryRs 58 Cr
Other liabilitiesRs 98 Cr
Shares outstanding (crore)0.57
Ownership
Promoter holding62.23% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 21.7 is at the 77th percentile of its own 8.9-year range (median 12.7, low 6.8, high 77.1).
P/B 1.25 is at the 61th percentile (median 1.20).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodALBERTDAVDNifty 50Difference
1 week-1.7%-2.8% +1.1 pts
1 month-1.7%-6.8% +5.1 pts
3 months+19.1%-7.6% +26.7 pts
6 months+45.9%+0.4% +45.5 pts
1 year+7.9%-9.9% +17.8 pts
2 years-42.5%-13.6% -29.0 pts
3 years+10.6%+14.2% -3.6 pts
5 years+44.7%+27.9% +16.8 pts

Red flags

F-score 2 of 8
explainWeak cash conversion Cash from operations was 10% of net profit over the last 3 years
explainReceivables outrunning sales Receivables grew 24% vs sales -4% in 2026
explainDebt up, profit down Borrowings up 140% while net profit fell in 2026
lookProfit leans on other income Other income was 1406% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹101 Cr +42.3% vs Jun 2025. Net profit ₹32 Cr +300.0%.
Against our estimate for Jun 2026: sales +27.5%, profit +933.4% beat. Our estimate for Sep 2026: sales Rs 112 Cr, profit Rs 7 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-30Dividend - Rs 5 Per Share
2025-07-25Dividend - Rs 5 Per Share
2024-08-02Dividend - Rs 11.50 Per Share
2024-08-02Annual General Meeting
2023-08-03Dividend - Rs 9 Per Share
2023-08-03Annual General Meeting
2022-08-01Annual General Meeting/Dividend - Rs 9 Per Share
2021-09-06 Dividend - Rs 6 Per Share
2021-09-06 Annual General Meeting
2020-09-16 Annual General Meeting
2020-03-13 Interim Dividend - Rs 7 Per Share
2019-08-01 Annual General Meeting/Dividend - Rs 6 Per Share
2018-08-24 Annual General Meeting/Dividend- Rs 5.50 Per Share
2017-09-01 Annual General Meeting/Dividend - Rs 5.50 Per Share
2016-09-01 Annual General Meeting
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 days

Quick answers

What is the market cap of Albert David Ltd?

Albert David Ltd (ALBERTDAVD) has a market capitalisation of Rs 499 Cr. at the 2026-10-01 close.

What is the P/E ratio of Albert David Ltd?

Albert David Ltd trades at a P/E of 22.1 on trailing twelve-month profit, at the 2026-10-01 close.

What were Albert David Ltd's latest quarterly results?

In the Jun 2026 quarter, Albert David Ltd sales was Rs 101 Cr (+42.3% vs Jun 2025) and net profit was Rs 32 Cr.

What is the 52-week high and low of Albert David Ltd?

The 52-week high is Rs 931.85 and the 52-week low is Rs 579.90.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03